SCI/PUBMED gelistet | alle Publikationstypen | Gesamt nach Jahr und Erstautor | MUG-Autor*innen |
** = Publikationen gelistet in SCI/SSCI/Pubmed
** Agrawal, D; Cisarova, K; Vosberg, S; Allmendinger, F; Munkhbaatar, E; Dandachi, N; Fernandez, Hernandez, FJ; Tonietto, M; Jäger, V; Anton, M; Keller, EC; Jesinghaus, M; Meinhardt, AL; Haefner, V; Stoeger, T; Steiger, K; McGranahan, N; Dengler, MA; Wahida, A; Jost, PJ
Aberrant methylation limits antitumoral inflammation in lung adenocarcinoma by restricting RIPK3 expression.
Sci Adv. 2026; 12(4):eadz9227
Doi: 10.1126/sciadv.adz9227
PubMed
FullText
FullText_MUG
** Seiler, I; Schäfer, S; von, Wachter, C; Balermpas, P; Slavik, M; Burkon, P; Meents, J; Kästner, L; Lohaus, F; Willner, J; Schunn, AS; Drabke, S; Klischies, K; Wittenstein, O; Bank, P; Partl, R; Müller, JA; Gawish, A; Grün, A; Baehr, A; Trommer, M; Glasmacher, A; Mader, T; Holy, R; Dzierma, Y; Ehret, F; Rühle, A; Guckenberger, M; Moustakis, C; Brunner, T; Blanck, O; Boda-Heggemann, J; Nicolay, NH; Nägler, F
Impact of target volume and dose concepts on the outcomes of prostate cancer patients treated with stereotactic body radiotherapy for spinal metastases - a European multicenter cohort study.
Radiother Oncol. 2025; 214:111276
Doi: 10.1016/j.radonc.2025.111276
Web of Science
PubMed
FullText
FullText_MUG